Compare Baidu Inc (BIDU) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baidu Inc vs Recursion Pharmaceuticals Inc — how do they compare? Baidu Inc trades at $104.74 (market cap $36.18B), while Recursion Pharmaceuticals Inc trades at $3.38 (market cap $1.81B). The key difference: Baidu Inc is far larger — about 20× Recursion Pharmaceuticals Inc's market cap, and Baidu Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| BIDU | RXRX | |
|---|---|---|
Market Cap | $36.18B | $1.81B |
Sector | Media | Health |
52-Week High | $162.52 | $6.79 |
52-Week Low | $86.76 | $2.84 |
Enterprise Value | $32.81B | $1.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baidu (BIDU) trades at $109.50, down 0.19% on the day, with technicals indicating a bearish trend and key support at $108. The company reported a sharp decline in net income to $5.59 billion in 2025, with margins contracting, though it beat EPS estimates in two of the last three quarters. Recent news highlights autonomous vehicle testing in London and a planned Q2 2026 earnings report on August 18, 2026.
The outlook is mixed: strong analyst buy ratings (75.47%) and a $169.80 price target suggest upside, but bearish technicals, profit margin pressures, and China market risks pose challenges. Investment opportunity hinges on AI and cloud growth offsetting advertising weakness, while risks include execution missteps and regulatory headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Baidu Inc
Baidu, Inc. operates an Internet search engine. The Company offers algorithmic search, enterprise search, news, MP3, and image searches, voice assistance, online storage, and navigation services. Baidu serves clients globally.
Read more on BIDU →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
